Tianda Pharmaceuticals Ltd ("Tianda Pharmaceuticals") is engaged in the research and development, manufacture and sales of pharmaceutical, biotechnology and healthcare products.

Headquartered in Hong Kong, Tianda Pharmaceuticals has set up sales and distribution centres in Shenzhen and Sydney, and established two pharmaceutical R&D and production bases in Zhuhai and Kunming. Both production bases are awarded Good Manufacturing Practice ("GMP") certifications issued by China Food and Drug Administration ("CFDA"). The production base in Zhuhai is even awarded GMP certification by Therapeutic Goods Administration ("TGA") of Australia.

Tianda Pharmaceuticals is listed on the Hong Kong Stock Exchange (Stock Code: 00455.HK). Tianda Group is its controlling stakeholder with a 55.56% stake.